会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明公开
    • 신규한 페닐피로펜 디, 이의 생산방법 및 이를 포함하는 약학적 조성물
    • 新型苯乙烯D,其制备方法及其包含的药物组合物
    • KR1020130100618A
    • 2013-09-11
    • KR1020120022012
    • 2012-03-02
    • 한국생명공학연구원
    • 김영국김중수김형진배경숙김지연문옥성윤원기이성윤
    • C07D493/04A61K31/35A61P9/00A61P25/28
    • PURPOSE: Phenylpyropene D and a pharmaceutical composition containing the same are provided to effectively suppress the activity of acyl coA:acyl cholesterol transferase, thereby preventing or treating cardiovascular diseases or Alzheimer's disease. CONSTITUTION: Phenylpyropene D of chemical formula 1 is provided. A method for preparing phenylpyropene D or pyripyropene comprises the steps of: culturing Penicillium griseofulvum; and isolating and purifying phenylpyropene D of chemical formula 1 or pyripyropene A of chemical formula 2 from the cultured liquid. A compound (C_30H_36O_9) is isolated from C_30H_36O_9 (deposit number : KCTC 11759BP). A pharmaceutical composition for preventing or treating cardiovascular diseases or Alzheimer's disease contains phenylpyropene D of chemical formula 1 and/or a pharmaceutically acceptable salt thereof.
    • 目的:提供苯基丙苯D和含有它们的药物组合物以有效抑制酰基辅酶A酰基胆固醇转移酶的活性,从而预防或治疗心血管疾病或阿尔茨海默氏病。 构成:提供化学式1的苯基丙苯D。 制备苯基丙醚D或吡柔比苯的方法包括以下步骤:培养青霉青霉; 并从培养液中分离和纯化化学式1的苯基丙醚D或化学式2的吡啶并芘A. 化合物(C_30H_36O_9)与C_30H_36O_9(保藏号:KCTC 11759BP)分离。 用于预防或治疗心血管疾病或阿尔茨海默氏病的药物组合物含有化学式1的苯基丙醚D和/或其药学上可接受的盐。
    • 13. 发明公开
    • 항진균제 표적 유전자 및 항진균제 스크리닝 키트
    • 抗真菌药物的目标基因和含有靶基因突变株的抗真菌药物筛选试剂盒
    • KR1020040083756A
    • 2004-10-06
    • KR1020030018359
    • 2003-03-25
    • 한국생명공학연구원
    • 원미선유향숙장영주정경숙박조영허광래김동욱김지연길영숙안지희류영권박한오최영철
    • C12N15/31
    • C12Q1/18C12Q1/025
    • PURPOSE: A target gene of an anti-fungal drug and a screening kit for the anti-fungal drug containing a mutant strain from which the target gene deleted are provided, thereby easily detecting the target gene of an anti-fungal drug, and easily screening a novel anti-fungal drug. CONSTITUTION: The target gene of an anti-fungal drug is selected from genes consisting of GenBank #AL672257(Expasy #Q9P6R0), GenBank #AL391604(Expasy #CAC05249), GenBank #AL672256(Expasy #Q09869), GenBank #AL672256(Expasy #P56286), GenBank #059679(Expasy #059679), GenBank #Z99164(Expasy #Q10279) and GenBank #AL033127(Expasy #CAA21865) which are reactive to polyene macrolide anti-fungal drug such as amphotericin B. The screening kit for the anti-fungal drug comprises target gene deleted heterozygote mutant fission yeast. A method for screening anti-fungal drug candidates comprises the steps of: (1) culturing the mutant fission yeast in a medium containing anti-fungal drug candidates; and (2) comparing the growth of the mutant fission yeast with that of natural yeast and selecting the target gene deleted heterozygote mutant fission yeast showing reduced growth rate.
    • 目的:提供抗真菌药物的靶基因和含有缺失靶基因的突变株的抗真菌药物筛选试剂盒,从而容易地检测抗真菌药物的靶基因,并且容易筛选 一种新型抗真菌药物。 构成:抗真菌药物的靶基因选自GenBank#AL672257(Expasy#Q9P6R0),GenBank#AL391604(Expasy#CAC05249),GenBank#AL672256(Expasy#Q09869),GenBank#AL672256(Expasy# P56286),GenBank#059679(Expasy#059679),GenBank#Z99164(Expasy#Q10279)和GenBank#AL033127(Expasy#CAA21865),其与多烯大环内酯类抗真菌药如两性霉素B反应。 真菌药物包括靶基因缺失杂合突变体裂殖酵母。 用于筛选抗真菌药物候选物的方法包括以下步骤:(1)在含有抗真菌药物候选物的培养基中培养突变体裂殖酵母; 和(2)将突变裂殖酵母的生长与天然酵母的生长进行比较,并选择具有降低的生长速率的靶基因缺失的杂合突变体裂殖酵母。